查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1712506

全球電腦斷層掃描市場 - 2025-2033

Global Computed Tomography Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球電腦斷層掃描市場規模達到 43.9 億美元，預計到 2033 年將達到 82.1 億美元，在 2025-2033 年預測期內的複合年成長率為 7.6%。

電腦斷層掃描 (CT)，也稱為電腦軸向斷層掃描 (CAT)，是一種複雜的成像技術，它利用一束窄 X 光照射患者，並使其圍繞身體快速旋轉。此過程會產生訊號，經電腦處理後可產生橫斷面影像，稱為「切片」。與傳統 X 光相比，這些斷層掃描影像為臨床醫生提供了更詳細的資訊。

在檢查過程中，CT 機器的電腦會捕捉多個連續的切片。然後可以將這些切片以數位方式組合以形成患者解剖結構的3D（3D）表示。這種 3D 影像有助於更輕鬆地識別基本結構以及潛在的腫瘤或異常，從而提高診斷準確性並有助於治療計劃。

市場動態：

駕駛員和約束裝置

CT技術的創新

CT 技術的創新是全球電腦斷層掃描市場的關鍵驅動力。 CT技術的不斷創新，例如高切片掃描儀、雙能CT以及人工智慧的融合，顯著提高了影像品質和診斷準確性。此外，該行業的主要參與者整合了技術創新，從而推動了該市場的成長。

例如，2024 年 6 月，富士軟片醫療美洲公司推出了緊湊型 128 層 CT 系統（稱為 FCT iStream），在電腦斷層掃描 (CT) 市場取得了顯著進展。該系統已獲得 FDA 510(k) 批准，允許其在臨床環境中使用。

此外，2024 年 2 月，飛利浦在 2024 年歐洲放射學大會 (ECR) 上推出了支援人工智慧的 CT 5300 系統，以提高診斷準確性，同時使更廣泛的患者能夠以更實惠的價格獲得先進的影像服務。此創新系統旨在滿足臨床環境中對高效成像解決方案日益成長的需求。

設備成本高昂

購買和安裝先進的電腦斷層掃描 (CT) 系統的高成本對許多醫療機構，尤其是小型診所和醫院造成了重大障礙。這項初始投資可能會限制對最新成像技術的使用，尤其是在資源受限的環境中。

了解 CT 掃描儀的成本涉及瀏覽各種選項，每種選項都旨在滿足特定的成像需求並適應不同的預算。 CT 掃描儀有三個不同的價格等級：入門級、中級和高級。每個類別不僅由其價格範圍定義，還由所提供的技術水平和診斷能力定義，為醫療機構提供符合其營運要求的選擇。

根據 Block Imaging, Inc. 2024 年的資料，入門級 CT 掃描儀是最容易獲得的選擇，價格從 80,000 美元到 100,000 美元不等。中級 CT 掃描儀的價格在 120,000 美元到 160,000 美元之間，提供了增強的技術和功能。同時，高階 CT 掃描儀的價格從 20 萬美元到 30 萬美元不等，採用先進的影像技術，可以滿足更複雜的診斷需求。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第2章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按類型分類的程式碼片段
  • 技術片段
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第3章：動態

  • 影響因素
    • 驅動程式
      • CT技術的創新
      • 慢性病盛行率上升
    • 限制
      • 設備成本高昂
      • 嚴格的監管要求
    • 機會
      • 預防性醫療保健需求不斷成長
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的既定領導者
    • 擁有成熟產品的市場領導者
  • 最新進展與突破
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 南美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第5章：電腦斷層掃描市場（按類型）

  • 固定式CT
  • 攜帶式CT

第6章：電腦斷層掃描市場（依技術）

  • 高切CT
  • 中層CT
  • 低層次CT
  • 錐形束CT（CBCT）

第7章：電腦斷層掃描市場（依應用）

  • 腫瘤學
  • 心臟病學
  • 新興醫學
  • 神經血管
  • 肌肉骨骼
  • 其他

第 8 章：電腦斷層掃描市場（依最終使用者分類）

  • 醫院
  • 診斷影像中心
  • 其他

第9章：電腦斷層掃描市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第10章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 11 章：公司簡介

  • Siemens Healthcare Private Limited
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 併購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT分析
  • GE HealthCare.
  • Canon Medical Systems, USA.
  • Koninklijke Philips NV
  • FUJIFILM India Private Limited
  • Neusoft Medical Systems
  • United Imaging Healthcare Co., Ltd.
  • Koning Health.
  • NeuroLogica Corp.
  • Shenzhen Anke High-tech Co., Ltd.
  • Planmed Oy
  • Stryker

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: MA245

The global computed tomography market reached US$ 4.39 billion in 2024 and is expected to reach US$ 8.21 billion by 2033, growing at a CAGR of 7.6 % during the forecast period of 2025-2033.

Computed tomography (CT), also known as computerized axial tomography (CAT), is a sophisticated imaging technique that utilizes a narrow beam of X-rays directed at a patient, which rapidly rotates around the body. This process generates signals that are processed by a computer to create cross-sectional images, referred to as "slices." These tomographic images provide clinicians with more detailed information compared to conventional X-rays.

During the procedure, the CT machine's computer captures multiple successive slices. These slices can then be digitally combined to form a three-dimensional (3D) representation of the patient's anatomy. This 3D imaging facilitates the easier identification of fundamental structures, as well as potential tumors or abnormalities, thereby enhancing diagnostic accuracy and aiding in treatment planning.

Market Dynamics: Drivers & Restraints

Innovations in CT Technology

Innovations in CT technology are crucial drivers for the global computed tomography market. Ongoing innovations in CT technology, such as high-slice scanners, dual-energy CT, and the integration of artificial intelligence, significantly improve imaging quality and diagnostic accuracy. Furthermore, key players in the industry integrate innovations in the technology that would drive this market growth.

For instance, in June 2024, FUJIFILM Healthcare Americas Corporation made notable advancements in the computed tomography (CT) market by launching its compact, 128-slice CT system known as the FCT iStream. This system has received FDA 510(k) clearance, allowing it to be utilized in clinical settings.

Additionally, in February 2024, Philips unveiled the AI-enabled CT 5300 system at the European Congress of Radiology (ECR) 2024 to improve diagnostic accuracy while making advanced imaging more affordable and accessible to a broader range of patients. This innovative system is designed to meet the increasing demand for efficient and effective imaging solutions in clinical environments.

High Costs of Equipment

The high costs associated with purchasing and installing advanced computed tomography (CT) systems create a significant barrier for many healthcare facilities, particularly smaller clinics and hospitals. This initial investment can restrict access to the latest imaging technologies, especially in resource-constrained environments.

Understanding the cost of a CT scanner involves navigating various options, each designed to meet specific imaging needs and accommodate different budgets. There are three distinct price tiers for CT scanners: Entry Level, Intermediate, and Premium. Each category is defined not only by its price range but also by the level of technology and diagnostic capabilities offered, providing healthcare facilities with choices that align with their operational requirements.

According to the Block Imaging, Inc. data in 2024, stated that entry-level CT scanners are the most accessible option, with prices ranging from $80,000 to $100,000. The intermediate tier of CT scanners, priced between $120,000 and $160,000, provides enhanced technology and capabilities. Meanwhile, the premium tier of CT scanners, which range from $200,000 to $300,000, features advanced imaging technologies for more complex diagnostic needs.

Segment Analysis

The global computed tomography market is segmented based on type, technology, application, end-user, and region.

Technology:

The high-slice CT segment in technology is expected to dominate the global computed tomography market with the highest market share

High-slice CT scanners, typically encompassing systems with more than 128 slices (such as 256-, 320-, and 640-slice models), these systems offer faster scan times, increased patient throughput, and lower radiation doses, making them ideal for advanced diagnostic imaging across multiple medical disciplines, including cardiology, neurology, oncology, gastroenterology, and pediatrics.

High-slice CT scanners provide enhanced image clarity, which is crucial for detecting microcalcifications, vascular abnormalities, and early-stage cancers. Innovations such as AI integration, improved dose reduction techniques, and photon-counting CT technology (as seen in Siemens Healthineers' Naeotom Alpha series) are propelling this segment forward. These CT scanners are highly valuable for non-invasive coronary imaging, offering precise assessment of cardiovascular diseases, particularly in patients with irregular heart rates.

For instance, in December 2024, Siemens Healthineers' introduction of the Naeotom Alpha.Pro and Naeotom Alpha. Prime represents a breakthrough in high-slice CT imaging by integrating photon-counting detector (PCD) technology into the field. These additions mark a significant advancement in CT imaging, offering higher resolution, reduced radiation dose, and improved workflow efficiency.

High-slice CT scanners, such as 128-slice, 256-slice, and 320-slice systems, capture large volumes of data with greater speed and resolution. However, conventional high-slice CT scanners still rely on energy-integrating detectors (EIDs), which have limitations in signal processing and image quality. These factors have solidified the segment's position in the global computed tomography market.

Geographical Analysis

North America is expected to hold a significant position in the global computed tomography market with the highest market share

The increasing incidence of chronic illnesses, such as cancer and cardiovascular diseases, is a major driver of CT scanner demand. In particular, oncology applications are seeing significant growth due to higher rates of cancer diagnoses and expanded screening programs, such as low-dose CT scans for lung cancer detection in high-risk groups.

North America, especially the U.S., is witnessing rapid advancements in CT scanner technology, including AI-powered image analysis, photon-counting detectors, and improved resolution with lower radiation doses. Companies like Siemens Healthineers, GE Healthcare, and Canon Medical Systems are investing heavily in research and innovation.

The U.S. government and private institutions are increasing investments in healthcare infrastructure, particularly in advanced diagnostic imaging. The National Institute of Health (NIH) has allocated billions of dollars for cancer and cardiovascular disease research, further boosting the adoption of CT imaging for early disease detection.

Furthermore, key players' product launches and approvals would drive this market growth. For instance, in June 2025, Fujifilm Healthcare Americas Corporation received FDA 510(k) clearance for its new 128-slice computed tomography (CT) system, the FCT iStream. This CT system is designed to provide high-quality imaging while enhancing efficiency and reducing patient radiation exposure. Thus, the above factors are consolidating the region's position as a dominant force in the global computed tomography market.

Competitive Landscape

The major global players in the computed tomography market include Siemens Healthcare Private Limited, GE HealthCare, Canon Medical Systems, USA., Koninklijke Philips N.V., FUJIFILM India Private Limited, Neusoft Medical Systems, United Imaging Healthcare Co., Ltd., Koning Health, NeuroLogica Corp., Shenzhen Anke High-tech Co., Ltd., Planmed Oy, and Stryker among others.

Key Developments

  • In December 2024, CarePlus International Clinics officially inaugurated a cutting-edge Diagnostic Imaging Center that features MRI and CT scan services integrated with advanced Artificial Intelligence (AI) technology. The integration of AI into these imaging technologies is expected to improve the accuracy and efficiency of diagnostic procedures, ultimately benefiting patient care and health outcomes.
  • In July 2024, Trivitron Healthcare reached a significant milestone by becoming the first Indian company to secure regulatory approvals from the Bureau of Indian Standards (BIS), the Atomic Energy Regulatory Board (AERB), and the Central Drugs Standard Control Organization (CDSCO) for the manufacturing of CT scanners.
  • In February 2024, Koning Health announced that it had received regulatory clearance from the Federal Authority for Nuclear Regulation (FANR) in the United Arab Emirates (UAE). This approval enables Koning to introduce its innovative breast computed tomography (CT) technology, specifically the Vera Complete system, into the UAE market.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global computed tomography market report delivers a detailed analysis with 76 key tables, more than 67 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Innovations in CT Technology
      • 3.1.1.2. Rising Prevalence of Chronic Diseases
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs of Equipment
      • 3.1.2.2. Strict Regulatory Requirements
    • 3.1.3. Opportunity
      • 3.1.3.1. Increasing Demand for Preventive Healthcare
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Latest Developments and Breakthroughs
  • 4.3. Regulatory and Reimbursement Landscape
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. Asia Pacific
    • 4.3.4. South America
    • 4.3.5. Middle East & Africa
  • 4.4. Porter's Five Forces Analysis
  • 4.5. Supply Chain Analysis
  • 4.6. Patent Analysis
  • 4.7. SWOT Analysis
  • 4.8. Unmet Needs and Gaps
  • 4.9. Recommended Strategies for Market Entry and Expansion
  • 4.10. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.11. Pricing Analysis and Price Dynamics

5. Computed Tomography Market, By Type

  • 5.1. Introduction
    • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Stationary CT *
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Portable CT

6. Computed Tomography Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. High-Slice CT*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Mid-Slice CT
  • 6.4. Low-Slice CT
  • 6.5. Cone Beam CT (CBCT)

7. Computed Tomography Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Oncology*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiology
  • 7.4. Emerging Medicine
  • 7.5. Neurovascular
  • 7.6. Musculoskeletal
  • 7.7. Others

8. Computed Tomography Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Diagnostic Imaging Centers
  • 8.4. Others

9. Computed Tomography Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Siemens Healthcare Private Limited*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. GE HealthCare.
  • 11.3. Canon Medical Systems, USA.
  • 11.4. Koninklijke Philips N.V.
  • 11.5. FUJIFILM India Private Limited
  • 11.6. Neusoft Medical Systems
  • 11.7. United Imaging Healthcare Co., Ltd.
  • 11.8. Koning Health.
  • 11.9. NeuroLogica Corp.
  • 11.10. Shenzhen Anke High-tech Co., Ltd.
  • 11.11. Planmed Oy
  • 11.12. Stryker

LIST NOT EXHAUSTIVE

12. Assumptions and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us